Get started
Author

Shunsuke Okumura

Observed name: SHUNSUKE OKUMURA
ORCID: 0000-0003-2807-1022
Observed ORCID: 0000-0003-2807-1022
OpenAlex ID: A5060359509
Prostaglandin I 2 Promotes Recruitment of Endothelial Progenitor Cells and Limits Vascular Remodeling
2009 · Jun-ichi Kawabe, Koh-ichi Yuhki, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 75
Nicotinamide Phosphoribosyltransferase: A Potent Therapeutic Target in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor-Gene Mutation
2011 · Shunsuke Okumura, Takaaki Sasaki, et al. · Journal of Thoracic Oncology · 44
Prostacyclin Stimulated Integrin-Dependent Angiogenic Effects of Endothelial Progenitor Cells and Mediated Potent Circulation Recovery in Ischemic Hind Limb Model
2012 · Yoko Aburakawa, Jun-ichi Kawabe, et al. · Circulation Journal · 34
PDF
Molecular Pathways: The Basis for Rational Combination Using MEK Inhibitors in KRAS-Mutant Cancers
2014 · Shunsuke Okumura, Pasi A. Jänne · Clinical Cancer Research · 32
Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer
2017 · Ryohei Yoshida, Takaaki Sasaki, et al. · International Journal of Oncology · 30
PDF
Prostaglandin I2 analog suppresses lung metastasis by recruiting pericytes in tumor angiogenesis
2014 · YOSHINORI MINAMI, TAKAAKI SASAKI, et al. · International Journal of Oncology · 21
PDF
Feasibility of adjuvant chemotherapy with S-1 consisting of a 4-week administration and a two-week rest period in patients with completely resected non-small cell lung cancer
2012 · SHUNSUKE OKUMURA, TAKAAKI SASAKI, et al. · Molecular and Clinical Oncology · 19
PDF
Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials
2018 · Toshiyuki Harada, Toraji Amano, et al. · Frontiers in Pharmacology · 18
PDF
Monomerization of ALK Fusion Proteins as a Therapeutic Strategy in ALK-Rearranged Non-small Cell Lung Cancers
2020 · Noriko Hirai, Takaaki Sasaki, et al. · Frontiers in Oncology · 17
PDF
Cyclin-dependent kinase 4 upregulation mediates acquired resistance of dabrafenib plus trametinib in BRAF V600E-mutated lung cancer
2021 · Noriko Hirai, Yutaka Hatanaka, et al. · Translational Lung Cancer Research · 11
PDF
The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer
2021 · Satoshi Okazaki, Takaaki Sasaki, et al. · Oncology Letters · 8
PDF
Pharmacokinetics of garenoxacin in elderly patients with respiratory tract infections
2010 · Yoshinobu Ohsaki, Kazutoyo Morita, et al. · International Journal of Antimicrobial Agents · 7
Novel ALK-specific mRNA in situ hybridization assay for non-small-cell lung carcinoma
2020 · Noriko Hirai, Takaaki Sasaki, et al. · Translational Lung Cancer Research · 6
PDF
Observation of Zn-photoprotoporphyrin red Autofluorescence in human bronchial cancer using color-fluorescence endoscopy
2017 · Yoshinobu Ohsaki, Takaaki Sasaki, et al. · BMC Cancer · 5
Detection of resistance mutations in patients with anaplastic lymphoma kinase-rearranged lung cancer through liquid biopsy
2023 · Takaaki Sasaki, Ryohei Yoshida, et al. · Translational Lung Cancer Research · 4
PDF
Histamine H1 antagonist levocetirizine as a potential cause of lung injury
2015 · Satoshi Endo, Yasushi Yamamoto, et al. · Respirology Case Reports · 2
PDF
SETD2 Deficiency and Mir-21: Potent Therapeutic Targets in NUT Midline Carcinoma
2022 · Nana Yoshida, Shunsuke Okumura, et al. · Journal of Cancer Science and Clinical Therapeutics · 1
Acute eosinophilic pneumonia following inhalation of turpentine oil: A case report
2020 · Yasuhiro Umekage, Shunsuke Okumura, et al. · Respiratory Medicine Case Reports · 1
PDF
Long-term follow-up of pharmacokinetics (PK) and immunogenicity of the anti–PD-1 antibodies nivolumab (Nivo) and pembrolizumab (Pembro) in real-world practice.
2019 · Masahide Fukudo, Kazuto Mishima, et al. · Journal of Clinical Oncology · 1
Prevalence, genetic features, and anti-cancer drug sensitivity of NUT midline carcinoma
2018 · Shunsuke Okumura, Nana Takahashi, et al. · Annals of Oncology · 1
Abstract 3148: Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer
2017 · Ryohei Yoshida, Takaaki Sasaki, et al. · Cancer Research · 1
Abstract 4379: Activating the prostaglandin I2-IP signaling suppresses metastasis in lung cancer
2012 · Yoshinori Minami, Satoshi Endo, et al. · Cancer Research · 1
Abstract 503: Longitudinal minimally invasive monitoring of resistance mutations in ALK rearranged lung cancer patients
2022 · Takaaki Sasaki, Noriko Hirai, et al. · Cancer Research
Fluorodynamic diagnosis of thoracic malignancies
2019 · Yoshinobu Ohsaki, Ryohei Yoshida, et al. · International Photodynamic Association World Congress
Abstract 648: Digital PCR in genetic diagnosis of NUT midline carcinoma
2018 · Shunsuke Okumura, Shin-ichi Chiba, et al. · Cancer Research
Works count: 34
Citation count: 339
H-index: 10
I10-index: 10
Year
Topic
Type